TPO therapy program (MedExGen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTPO therapy program (MedExGen)
Drug Alias NameThrombopoietin receptor modulator (MedExGen)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionThrombopoietin receptor modulators
TargetsThrombopoietin receptor
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedexgen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedexgen Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A